Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease arthritis
Phenotype C0007222|cardiovascular disease
Sentences 34
PubMedID- 20735865 Palomino-morales and colleagues [1] report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra).
PubMedID- 24498229 In observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity.
PubMedID- 23300117 Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward).
PubMedID- 23256829 The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus.
PubMedID- 21791140 In the multidisciplinary dutch guideline on cardiovascular risk management (revision 2011) the recommendation for preventive treatment of elevated risks of cardiovascular disease in patients with arthritis lacks a trial-based justification.
PubMedID- 22513132 The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized [1-4].
PubMedID- 23218811 Objective: arthritis is associated with cardiovascular diseases (cvds).
PubMedID- 22906083 cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care.
PubMedID- 21385539 Objectives: to assess the potential association between lep rs2167270 (19 g>a) gene polymorphism and disease susceptibility and cardiovascular disease (cv) in patients with rheumatoid arthritis (ra).
PubMedID- 23983474 The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms.
PubMedID- 24585741 Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied.
PubMedID- 24511540 For instance, angiopoietin-2 (angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation and thus is related to severity and cardiovascular disease in patients with rheumatoid arthritis [2].
PubMedID- 22419774 Coexistence of hypothyroidism with inflammatory arthritis is associated with cardiovascular disease in women.
PubMedID- 20638217 Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice.
PubMedID- 22085518 In the multidisciplinary dutch guideline on cardiovascular risk management (revision 2011) the recommendation for preventive treatment of elevated risks of cardiovascular disease in patients with arthritis lacks a trial-based justification.
PubMedID- 23244227 Objectives: to study cardiovascular autopsy findings and the lifetime prevalence of cardiovascular diseases (cvds) in patients with rheumatoid arthritis (ra).
PubMedID- 25754335 Rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease.
PubMedID- 20383550 Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 25969671 Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis [2], and strong evidences from basic research and epidemiological studies support that inflammation and venous thrombosis are associated processes [3].
PubMedID- 22808986 Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 21520672 [excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause.
PubMedID- 22691241 The impact of these biochemical changes in modifying the burden of cardiovascular disease in patients with chronic inflammatory arthritis remains to be seen.
PubMedID- 21073447 To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed.
PubMedID- 25026799 [cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy].
PubMedID- 23079082 Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations.
PubMedID- 26362702 Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 20952464 Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.
PubMedID- 20868308 Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd).
PubMedID- 23666917 Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte).
PubMedID- 24206172 Objective: the increased incidence of cardiovascular disease (cvd) in patients with psoriatic arthritis (psa) has been reported previously.
PubMedID- 20647995 Both cachexia and cardiovascular disease are strongly associated with rheumatoid arthritis (ra) and linked to the chronic inflammatory process.
PubMedID- 25669439 The aim of this study was to investigate the presence of subclinical atherosclerosis among psoriatic arthritis (psa) patients without any cardiovascular disease (cvd) or traditional cardiovascular risk factors through measurement of endothelial function and carotid intima-media thickness (imt) and correlated with disease-related risk factors.
PubMedID- 22935383 Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown.
PubMedID- 23818136 Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score [frs]).

Page: 1